Cargando…

Long COVID-19 in Heart Transplant Recipients

PURPOSE: The goal of this study was to assess the frequency and common symptoms of post-acute COVID-19 syndrome (Long COVID-19) in heart transplant recipients (HTR). METHODS: After obtaining IRB approval, we conducted telephone surveys of HTR (n=30) who had tested positive for SARS-CoV-2 to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigler, R., Chen, B., Bharti, A., Aslam, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988701/
http://dx.doi.org/10.1016/j.healun.2022.01.682
_version_ 1784683021172998144
author Sigler, R.
Chen, B.
Bharti, A.
Aslam, S.
author_facet Sigler, R.
Chen, B.
Bharti, A.
Aslam, S.
author_sort Sigler, R.
collection PubMed
description PURPOSE: The goal of this study was to assess the frequency and common symptoms of post-acute COVID-19 syndrome (Long COVID-19) in heart transplant recipients (HTR). METHODS: After obtaining IRB approval, we conducted telephone surveys of HTR (n=30) who had tested positive for SARS-CoV-2 to evaluate their experience with acute COVID-19 illness and assess symptoms of Long COVID-19. Symptoms at onset and also beyond 6, 12, and 24 weeks of the initial diagnosis were recorded. Additionally, medical charts were reviewed for detailed information regarding transplant history, immunosuppression, COVID-19 management and hospitalization, and COVID-19 vaccination status. RESULTS: As noted in Table 1, among the 30 participants, 10 (33%) had symptoms consistent with Long COVID-19. Those with Long COVID-19 were more symptomatic during acute illness, with 40% of patients reporting cough, fevers or chills, and headaches, compared with 15%, 25%, and 20% respectively in those without Long COVID-19. Emergency department visits at initial illness (80% vs. 20%) and admission to the intensive care unit were more frequent (60% vs. 5%) in the Long COVID-19. Symptoms of Long COVID-19 lasted for a median of 9 weeks with 30% reporting ongoing symptoms at week 24. The most common persistent symptoms were depression, confusion, and difficulty concentrating. CONCLUSION: This study is an early investigation of a complex syndrome of Long COVID-19 in transplant patients. Long COVID-19 is not well described in the transplant setting. HTR at our center with Long COVID-19 were sicker at their initial COVID-19 diagnosis and had more emergency room visits, hospital admissions, and longer hospital stays than those without subsequent Long COVID-19. Although, recall bias could affect participants’ ability to remember details and symptoms, this would have impacted both groups similarly as the time since COVID-19 diagnosis to study enrollment was similar between the two groups. These are preliminary findings and the study is currently ongoing.
format Online
Article
Text
id pubmed-8988701
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89887012022-04-11 Long COVID-19 in Heart Transplant Recipients Sigler, R. Chen, B. Bharti, A. Aslam, S. J Heart Lung Transplant (661) PURPOSE: The goal of this study was to assess the frequency and common symptoms of post-acute COVID-19 syndrome (Long COVID-19) in heart transplant recipients (HTR). METHODS: After obtaining IRB approval, we conducted telephone surveys of HTR (n=30) who had tested positive for SARS-CoV-2 to evaluate their experience with acute COVID-19 illness and assess symptoms of Long COVID-19. Symptoms at onset and also beyond 6, 12, and 24 weeks of the initial diagnosis were recorded. Additionally, medical charts were reviewed for detailed information regarding transplant history, immunosuppression, COVID-19 management and hospitalization, and COVID-19 vaccination status. RESULTS: As noted in Table 1, among the 30 participants, 10 (33%) had symptoms consistent with Long COVID-19. Those with Long COVID-19 were more symptomatic during acute illness, with 40% of patients reporting cough, fevers or chills, and headaches, compared with 15%, 25%, and 20% respectively in those without Long COVID-19. Emergency department visits at initial illness (80% vs. 20%) and admission to the intensive care unit were more frequent (60% vs. 5%) in the Long COVID-19. Symptoms of Long COVID-19 lasted for a median of 9 weeks with 30% reporting ongoing symptoms at week 24. The most common persistent symptoms were depression, confusion, and difficulty concentrating. CONCLUSION: This study is an early investigation of a complex syndrome of Long COVID-19 in transplant patients. Long COVID-19 is not well described in the transplant setting. HTR at our center with Long COVID-19 were sicker at their initial COVID-19 diagnosis and had more emergency room visits, hospital admissions, and longer hospital stays than those without subsequent Long COVID-19. Although, recall bias could affect participants’ ability to remember details and symptoms, this would have impacted both groups similarly as the time since COVID-19 diagnosis to study enrollment was similar between the two groups. These are preliminary findings and the study is currently ongoing. Published by Elsevier Inc. 2022-04 2022-04-07 /pmc/articles/PMC8988701/ http://dx.doi.org/10.1016/j.healun.2022.01.682 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle (661)
Sigler, R.
Chen, B.
Bharti, A.
Aslam, S.
Long COVID-19 in Heart Transplant Recipients
title Long COVID-19 in Heart Transplant Recipients
title_full Long COVID-19 in Heart Transplant Recipients
title_fullStr Long COVID-19 in Heart Transplant Recipients
title_full_unstemmed Long COVID-19 in Heart Transplant Recipients
title_short Long COVID-19 in Heart Transplant Recipients
title_sort long covid-19 in heart transplant recipients
topic (661)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988701/
http://dx.doi.org/10.1016/j.healun.2022.01.682
work_keys_str_mv AT siglerr longcovid19inhearttransplantrecipients
AT chenb longcovid19inhearttransplantrecipients
AT bhartia longcovid19inhearttransplantrecipients
AT aslams longcovid19inhearttransplantrecipients